Direct preparation of unprotected aminimides (R3N+–NH) from natural aliphatic tertiary alkaloids (R3N) by [Mn(TDCPP)Cl]-catalysed N-amination reaction

Chemical Communications
2020.0

Abstract

A panel of natural aliphatic tertiary alkaloids (R3N) were directly converted to R3N+-NH- (without the need to prepare protected aminimides R3N+-NR'(-) followed by deprotection) by [Mn(TDCPP)Cl]catalysed N-amination reaction, with O-(2,4-dinitrophenyl) hydroxylamine as the nitrogen source, in up to 98% yields under mild reaction conditions.

Knowledge Graph

Similar Paper

Direct preparation of unprotected aminimides (R<sub>3</sub>N<sup>+</sup>–NH<sup>−</sup>) from natural aliphatic tertiary alkaloids (R<sub>3</sub>N) by [Mn(TDCPP)Cl]-catalysed N-amination reaction
Chemical Communications 2020.0
Synthesis of Tertiary Amines through Extrusive Alkylation of Carbamates
Organic Letters 2022.0
Addition of amines to methyl 3-dehydroquinate and 3-dehydroshikimate
Bioorganic &amp; Medicinal Chemistry Letters 1993.0
Access to New Cytotoxic Bisindole Alkaloids by a Modified Borch Reductive Amination Process
HETEROCYCLES 2000.0
Arylboronic Acid-Catalyzed C-Allylation of Unprotected Oximes: Total Synthesis of N-Me-Euphococcine
Organic Letters 2020.0
P<sub>4</sub>O<sub>10</sub>/TfOH mediated domino condensation–cyclization of amines with diacids: a route to indolizidine alkaloids under catalyst- and solvent-free conditions
RSC Advances 2022.0
Activating Imides with Triflic Acid: A General Intramolecular Aldol Condensation Strategy Toward Indolizidine, Quinolizidine, and Valmerin Alkaloids
Organic Letters 2020.0
Generation and Reactivity of 2-Amido-1,3-diaminoallyl Cations: Cyclic Guanidine Annulations via Net (3 + 2) and (4 + 3) Cycloadditions
Organic Letters 2020.0
Biopatterned Reorganization of Alkaloids Enabled by Ring-Opening Functionalization of Tertiary Amines
Journal of the American Chemical Society 2021.0
Highly Enantioselective and Practical Cinchona-Derived Phase-Transfer Catalysts for the Synthesis of α-Amino Acids This work was supported by grants from Aminogen Co. (Korea) through the Research Center of New Drug Development of Seoul National University and the Research Institute of Pharmaceutical Sciences in the College of Pharmacy of Seoul National University.
Angewandte Chemie International Edition 2002.0